Hedge Fund and Insider Trading News: Jeffrey Ubben, Tom Steyer, Chris Hohn, Coatue Management, Silver Lake Partners, Armistice Capital, Zscaler Inc (ZS), Canadian National Railway (CNI), and More
Jeff Ubben wants you to know he’s sorry.
Hedge Fund - Armistice Capital
Get Email AlertsSteven Boyd Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Armistice Capital |
| Manager | Steven Boyd |
| Portfolio Value | $5,171,408,000 |
| Change This QTR | +0.85% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | SPY | 24,000 | $1,083,936 | -15% | 20.96% | ||
| 2. | IEF | 28,000 | $574,756 | -7% | 11.11% | ||
| 3. | Travere Therapeutics Inc | 4,958,000 | $127,768 | +22% | 2.47% | ||
| 4. | INCY | 1,524,000 | $121,036 | -30% | 2.34% | ||
| 5. | BIIB | 572,000 | $120,463 | +25% | 2.32% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2022-06-21 | ||||
| 2022-06-17 | ||||
| 2022-05-20 | ||||
| 2022-03-15 | ||||
| 2022-02-15 |
News, Interviews and Investor Letters
Hedge Fund and Insider Trading News: Tom Steyer, Visium Asset Management, Cat Rock Capital, Central Pacific Financial Corp. (CPF), Comfort Systems USA, Inc. (FIX), and More
A recent example of activist success in Europe came on Monday in the form of a proposed merger between Just Eat and Takeaway.com to form a £9 billion ($10 billion) food delivery giant.
Hedge Fund and Insider Trading News: Kora Management, Glendon Capital, Armistice Capital, Hill International Inc (HIL), Athenex Inc (ATNX), and More
Jared Kushner, US President Donald Trump’s son-in-law, arrived in Jaisalmer on Friday, 23 November to attend his friend Nitin Saigal’s wedding.
13G Filing: Armistice Capital and Onconova Therapeutics Inc. (ONTX)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Intellipharmaceutics Intl Inc (IPCI)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Check Cap Ltd (CHEK)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Biopharmx Corp (BPMX)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13D Filing: Armistice Capital and Cerecor Inc (CERC)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d...
13G Filing: Armistice Capital and Tandem Diabetes Care Inc (TNDM)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Strongbridge Biopharma PLC (SBBP)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Apricus Biosciences Inc. (APRI)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13D Filing: Armistice Capital and Cerecor Inc (CERC)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d...
13G Filing: Armistice Capital and Aytu Bioscience Inc (AYTU)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
13G Filing: Armistice Capital and Depomed Inc (DEPO)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...
